Initiating Care of a Patient With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) by Charles W. Lapp

Get full text

Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning by Ashley R. Valdez, Elizabeth E. Hancock, Seyi Adebayo, David J. Kiernicki, Daniel Proskauer, John R. Attewell, Lucinda Bateman, Alfred DeMaria, Charles W. Lapp, Peter C. Rowe, Charmian Proskauer

Get full text

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. by David R Strayer, William A Carter, Bruce C Stouch, Staci R Stevens, Lucinda Bateman, Paul J Cimoch, Charles W Lapp, Daniel L Peterson, Chronic Fatigue Syndrome AMP-516 Study Group, William M Mitchell

Get full text

Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty C... by Elizabeth R. Unger, Jin-Mann S. Lin, Yang Chen, Monica E. Cornelius, Britany Helton, Anindita N. Issa, Jeanne Bertolli, Nancy G. Klimas, Elizabeth G. Balbin, Lucinda Bateman, Charles W. Lapp, Wendy Springs, Richard N. Podell, Trisha Fitzpatrick, Daniel L. Peterson, C. Gunnar Gottschalk, Benjamin H. Natelson, Michelle Blate, Andreas M. Kogelnik, Catrina C. Phan, on behalf of the MCAM Study Group

Get full text